Apixaban for Atrial Fibrillation and Systemic Fluconazole: Bleeding Risk and Possible Preventative Measures
- PMID: 36180183
- DOI: 10.1016/j.amjmed.2022.05.023
Apixaban for Atrial Fibrillation and Systemic Fluconazole: Bleeding Risk and Possible Preventative Measures
Comment in
-
The Reply.Am J Med. 2022 Oct;135(10):e407-e408. doi: 10.1016/j.amjmed.2022.06.008. Am J Med. 2022. PMID: 36180184 No abstract available.
Comment on
-
Bleeding Risk Following Systemic Fluconazole or Topical Azoles in Patients with Atrial Fibrillation on Apixaban, Rivaroxaban, or Dabigatran.Am J Med. 2022 May;135(5):595-602.e5. doi: 10.1016/j.amjmed.2021.11.008. Epub 2021 Nov 30. Am J Med. 2022. PMID: 34861201
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical